STOCK TITAN

[Form 4] CLOVER HEALTH INVESTMENTS, CORP. /DE Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Andrew Toy, who is listed as both Chief Executive Officer and a director of Clover Health Investments, Corp. (CLOV), reported a withholding disposition of 308,950 shares of Class A common stock on 10/01/2025 at a price of $2.62 per share to cover tax obligations arising from vested restricted stock units. After this withholding, the reporting person beneficially owns 10,165,562 shares. The filing explains these shares correspond to the automatic withholding for the vesting of 6.25% of RSUs originally granted on 01/01/2023; the remaining RSUs vest quarterly in equal 6.25% installments with a final vesting on 01/01/2027, subject to continued service.

Andrew Toy, che è elencato sia come Chief Executive Officer e come direttore di Clover Health Investments, Corp. (CLOV), ha riportato una ritenuta di 308.950 azioni ordinarie di Classe A in data 10/01/2025 al prezzo di $2.62 per azione per coprire gli obblighi fiscali derivanti dall'acquisizione di unità azionarie soggette a restrizioni (RSU) vestite. Dopo questa ritenuta, la persona che riferisce ha beneficiamente una proprietà di 10.165.562 azioni. L'atto spiega che tali azioni corrispondono all'automatico trattenimento per il vesting del 6.25% di RSU originariamente concesse il 01/01/2023; le RSU restanti vestono trimestralmente in rate uguali del 6.25% con un vesting finale il 01/01/2027, soggetto a continuità di servizio.

Andrew Toy, que figura como Chief Executive Officer y también director de Clover Health Investments, Corp. (CLOV), informó una disposición de retención de 308.950 acciones ordinarias de Clase A el 10/01/2025 a un precio de $2.62 por acción para cubrir las obligaciones fiscales derivadas de las RSU restringidas vestidas. Después de esta retención, la persona que presenta el informe posee beneficiosamente 10,165,562 acciones. El archivo explica que estas acciones corresponden al retiro automático para el vesting del 6.25% de las RSU originalmente concedidas el 01/01/2023; las RSU restantes vesting trimestralmente en cuotas iguales del 6.25% con un vesting final el 01/01/2027, sujeto a la continuidad del servicio.

Andrew ToyChief Executive Officer이자 Clover Health Investments, Corp. (CLOV)이사로도 등재되어 있으며, 10/01/2025에 주당 $2.62의 가격으로 양도한 제재된 RSU로 인해 발생하는 세금 의무를 충당하기 위하여 Class A 보통주 308,950주의 원천징수 처분을 보고했습니다. 이 원천징수 후 보고자는 유익하게 10,165,562주를 소유합니다. 기재는 이 수량이 원래 2023/01/01에 부여된 RSU의 6.25%가 vest되며 자동 원천징수에 해당한다고 설명합니다; 남은 RSU는 매 분기 동일한 6.25%의 분할로 vest되며 최종 vesting은 2027/01/01에 이루어지며, 지속적인 서비스에 달려 있습니다.

Andrew Toy, qui est répertorié comme Chief Executive Officer et également directeur de Clover Health Investments, Corp. (CLOV), a déclaré une disposition de retenue de 308 950 actions ordinaires de Classe A le 10/01/2025 à un prix de $2,62 par action pour couvrir les obligations fiscales résultant des RSU vestées. Après cette retenue, la personne déclarant possède bénéficiairement 10 165 562 actions. Le dépôt explique que ces actions correspondent à la retenue automatique pour le vesting de 6,25% des RSU initialement accordées le 01/01/2023; les RSU restantes vestent trimestriellement en parts égales de 6,25% avec un vesting final le 01/01/2027, sous réserve de la poursuite du service.

Andrew Toy, der sowohl als CEO als auch als Aufsichtsrat von Clover Health Investments, Corp. (CLOV) geführt wird, meldete eine einbehaltene Abgabe von 308.950 Stammaktien der Klasse A am 10/01/2025 zum Preis von $2,62 pro Aktie, um Steuerschulden aus vesteten RSUs zu decken. Nach dieser Abgabe besitzt die meldende Person unmittelbar 10.165.562 Aktien. Die Einreichung erläutert, dass diese Aktien dem automatischen withholding für das Vesting von 6,25% der ursprünglich am 01/01/2023 gewährten RSUs entsprechen; die verbleibenden RSUs vesten vierteljährlich in gleiche 6,25%-Raten mit einer endgültigen Vesting am 01/01/2027, vorbehaltlich fortgesetzter Dienster.

Andrew Toy، المدرج كلاً من الرئيس التنفيذي و< b>مدير في Clover Health Investments, Corp. (CLOV)، أبلغ عن إجراء حجز/اقتطاع من الأسهم بقيمة 308,950 سهماً من فئة A العادية في 10/01/2025 بسعر $2.62 للسهم لتغطية الالتزامات الضريبية الناشئة عن وحدات الأسهم المقيدة (RSU) التي تحققت. بعد هذا الحجز، يمتلك الشخص المبلغ تقريره بشكل فعّال 10,165,562 سهماً. توضح الإيداع أن هذه الأسهم مطابقة للاقتطاع التلقائي لل vesting لـ 6.25% من RSU الممنوحة أصلاً في 01/01/2023; vesting RSU المتبقية ربع سنويًا بنسب 6.25% متساوية مع vesting نهائي في 01/01/2027، رهناً باستمرار الخدمة.

Andrew Toy,同时列为 Chief Executive OfficerdirectorClover Health Investments, Corp. (CLOV),在 2025/10/01 以每股 $2.62 的价格就已归属的受限股票单位(RSU)产生的税务义务,披露了对 308,950 股 A 类普通股的预扣处理。此次预扣后,披露人实际持有 10,165,562 股。 filing 解释说,这些股票对应于自动预扣以 vest 6.25% 的 RSU,最初于 2023/01/01 授予;剩余的 RSU 将按季度等量 vest 6.25%,最终 vest 于 2027/01/01,前提是继续任职。

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Andrew Toy, che è elencato sia come Chief Executive Officer e come direttore di Clover Health Investments, Corp. (CLOV), ha riportato una ritenuta di 308.950 azioni ordinarie di Classe A in data 10/01/2025 al prezzo di $2.62 per azione per coprire gli obblighi fiscali derivanti dall'acquisizione di unità azionarie soggette a restrizioni (RSU) vestite. Dopo questa ritenuta, la persona che riferisce ha beneficiamente una proprietà di 10.165.562 azioni. L'atto spiega che tali azioni corrispondono all'automatico trattenimento per il vesting del 6.25% di RSU originariamente concesse il 01/01/2023; le RSU restanti vestono trimestralmente in rate uguali del 6.25% con un vesting finale il 01/01/2027, soggetto a continuità di servizio.

Andrew Toy, que figura como Chief Executive Officer y también director de Clover Health Investments, Corp. (CLOV), informó una disposición de retención de 308.950 acciones ordinarias de Clase A el 10/01/2025 a un precio de $2.62 por acción para cubrir las obligaciones fiscales derivadas de las RSU restringidas vestidas. Después de esta retención, la persona que presenta el informe posee beneficiosamente 10,165,562 acciones. El archivo explica que estas acciones corresponden al retiro automático para el vesting del 6.25% de las RSU originalmente concedidas el 01/01/2023; las RSU restantes vesting trimestralmente en cuotas iguales del 6.25% con un vesting final el 01/01/2027, sujeto a la continuidad del servicio.

Andrew ToyChief Executive Officer이자 Clover Health Investments, Corp. (CLOV)이사로도 등재되어 있으며, 10/01/2025에 주당 $2.62의 가격으로 양도한 제재된 RSU로 인해 발생하는 세금 의무를 충당하기 위하여 Class A 보통주 308,950주의 원천징수 처분을 보고했습니다. 이 원천징수 후 보고자는 유익하게 10,165,562주를 소유합니다. 기재는 이 수량이 원래 2023/01/01에 부여된 RSU의 6.25%가 vest되며 자동 원천징수에 해당한다고 설명합니다; 남은 RSU는 매 분기 동일한 6.25%의 분할로 vest되며 최종 vesting은 2027/01/01에 이루어지며, 지속적인 서비스에 달려 있습니다.

Andrew Toy, qui est répertorié comme Chief Executive Officer et également directeur de Clover Health Investments, Corp. (CLOV), a déclaré une disposition de retenue de 308 950 actions ordinaires de Classe A le 10/01/2025 à un prix de $2,62 par action pour couvrir les obligations fiscales résultant des RSU vestées. Après cette retenue, la personne déclarant possède bénéficiairement 10 165 562 actions. Le dépôt explique que ces actions correspondent à la retenue automatique pour le vesting de 6,25% des RSU initialement accordées le 01/01/2023; les RSU restantes vestent trimestriellement en parts égales de 6,25% avec un vesting final le 01/01/2027, sous réserve de la poursuite du service.

Andrew Toy, der sowohl als CEO als auch als Aufsichtsrat von Clover Health Investments, Corp. (CLOV) geführt wird, meldete eine einbehaltene Abgabe von 308.950 Stammaktien der Klasse A am 10/01/2025 zum Preis von $2,62 pro Aktie, um Steuerschulden aus vesteten RSUs zu decken. Nach dieser Abgabe besitzt die meldende Person unmittelbar 10.165.562 Aktien. Die Einreichung erläutert, dass diese Aktien dem automatischen withholding für das Vesting von 6,25% der ursprünglich am 01/01/2023 gewährten RSUs entsprechen; die verbleibenden RSUs vesten vierteljährlich in gleiche 6,25%-Raten mit einer endgültigen Vesting am 01/01/2027, vorbehaltlich fortgesetzter Dienster.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Toy Andrew

(Last) (First) (Middle)
C/O CLOVER HEALTH INVESTMENTS, CORP.
NOT APPLICABLE

(Street)
WILMINGTON DE 19801

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CLOVER HEALTH INVESTMENTS, CORP. /DE [ CLOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 10/01/2025 F 308,950(1) D $2.62 10,165,562 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 1, 2025, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date.
Remarks:
/s/Peter J. Rivas as attorney-in-fact for Andrew Toy 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CLOV CEO Andrew Toy report on 10/01/2025?

He reported an automatic withholding disposition of 308,950 Class A shares at $2.62 per share to cover taxes on vested RSUs.

How many CLOV shares does Andrew Toy beneficially own after the transaction?

The filing shows he beneficially owns 10,165,562 shares following the withholding.

Why were the 308,950 CLOV shares withheld?

They were withheld to cover tax obligations resulting from the vesting of 6.25% of RSUs granted on 01/01/2023.

When will the remaining RSUs vest for Andrew Toy?

The remaining RSUs vest quarterly in equal 6.25% installments, with the final vesting on 01/01/2027, subject to continued service.
Clover Health Investments Corp

NASDAQ:CLOV

CLOV Rankings

CLOV Latest News

CLOV Latest SEC Filings

CLOV Stock Data

1.30B
403.66M
3.88%
35.27%
9.43%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
JERSEY CITY